Researchers now have access to a burgeoning collection of tools for unravelling the epigenome, which could lead to new drug targets and ways to track disease. Laura Bonetta reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Johnson, D. S. et al. Genome Res. 18, 393–403 (2008).
Cokus, S. J. et al. Nature 452, 215–219 (2008).
Phanstiel, D. et al. Proc. Natl Acad. Sci. USA 105, 4093–4098 (2008).
Garcia, B. A., Pesavento, J. J., Mizzen, C. A. & Kelleher, N. L. Nature Methods 4, 487–489 (2007).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonetta, L. Detailed analysis. Nature 454, 796–798 (2008). https://doi.org/10.1038/454795a
Published:
Issue date:
DOI: https://doi.org/10.1038/454795a
